Jun Takei, Takayuki Inomata, Takuya Aoki, Shohei Nawate, Tatsuya Hirotsu, Keisuke Hatano, Mitsuyoshi Watanabe, Yasuto Noda, Masato Matsushima, Toshihiro Ishibashi, et al. Differences in neuroradiological impacts of hematoma volume and midline shift on clinical symptoms and recurrence rate in patients with unilateral chronic subdural hematoma. Journal of Clinical Neuroscience. 2025. 135. 111136-111136
Hiroaki Matsuzaki, Keitaro Kai, Yoshihiro Komohara, Hiromu Yano, Cheng Pan, Yukio Fujiwara, Rin Yamada, Ai Iwauchi, Nei Fukasawa, Toshihide Tanaka, et al. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages. Cancer Science. 2025
Ai Iwauchi, Nei Fukasawa, Jun Takei, Miku Maeda, Kyoichi Tomoto, Akihiko Teshigawara, Yohei Yamamoto, Yasuharu Akasaki, Yuzuru Hasegawa, Yuichi Murayama, et al. Comparative analyses of erythroblast transformation specific-1 related gene expression before and after neoadjuvant bevacizumab therapy for newly diagnosed glioblastoma. Int J Clin Exp Pathol. 2024. 17. 10. 346-359
Rintaro Tachi, Michiyasu Fuga, Toshihide Tanaka, Akihiko Teshigawara, Ikki Kajiwara, Koreaki Irie, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. The white-collar sign after Neuroform Atlas stent-assisted coil embolization of unruptured intracranial aneurysms. The Neuroradiology Journal. 2024
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranari, Yasuharu Akasaki, et al. Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain Tumor Pathology. 2024
Akasaki Y., Takei J., Yamamoto Y., Teshigawara A., Tohmoto K., Koseki H., Tanaka T., Murayama Y. IMT-2 Translational research for a multicenter clinical trial of tumor-fused dendritic cell immunotherapy. Neuro-Oncology Advances. 2024. vol 6(suppl;6). vol 6(suppl;6). iv10-iv10
Tanaka T., Iwauchi A., Fukasawa N., Takei J., Teshigawara A., Tohmoto K., Yamamoto Y., Hasegawa Y., Akasaki Y., Shimoda M., et al. ANG-1 Trial of multi-omics analyses using paired samples from newly diagnosed and recurrent glioblastoma during bevacizumab therapy. Neuro-Oncology Advances. 2024. vol 6(suppl;6). vol 6(suppl;6). iv1-iv1
Yohei Yamamoto, Toshihide Tanaka, Akihiko Teshigawara, Takuya Ishii, Yasuharu Akasaki, Yuichi Murayama. 10031- MET-5 CHANGES IN PROGNOSTIC FACTORS IN PATIENTS WITH BRAIN METASTASES FROM LUNG CANCER. Neuro-Oncology Advances. 2024. 6. Supplement_4. iv20-iv21
Kyoichi Tomoto, Akihiko Teshigawara, Toshihide Tanaka, Yuzuru Hasegawa, Yuichi Murayama. 10040- STMO-2 ASSOCIATED FACTORS LEADING TO INTRAOPERATIVE HYPOTENSION DUE TO THE USE OF 5-AMINOLEVLINIC ACID. Neuro-Oncology Advances. 2024. 6. Supplement_4. iv11-iv11